Loading...
Please wait, while we are loading the content...
Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Iiizumi, Megumi Bandyopadhyay, Sucharita Watabe, Kounosuke |
| Copyright Year | 2007 |
| Abstract | Tumor metastases suppressor protein KAI1/CD82 is capable of blocking the tumor metastases without affecting the primary tumor formation, and its expression is significantly down-regulated in many types of human cancers. However, the exact molecular mechanism of the suppressor function of KAI1 remains elusive. Evidence from our laboratory supports a model in which tumor cells dislodge from the primary tumor and intravasate into the blood or lymphatic vessels followed by attachment to the endothelial cell surface whereby KAI1 interacts with the Duffy antigen receptor for chemokines (DARC) protein. This interaction transmits a senescent signal to cancer cells expressing KAI1, whereas cells that lost KAI1 expression can proliferate, potentially giving rise to metastases. Our model of the mechanism of action of KAI1 shows that metastasis suppressor activity can be dependent on interaction with host tissue and explains how KAI1 suppresses metastasis without affecting primary tumor formation. Taken together, in vitro and in vivo studies identify the KAI1-DARC interaction as a potential target for cancer therapy. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://cancerres.aacrjournals.org/content/canres/67/4/1411.full.pdf |
| PubMed reference number | 17308076v1 |
| Volume Number | 67 |
| Issue Number | 4 |
| Journal | Cancer research |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | ACKR1 gene Blood Vessel CD82 protein, human CD82 wt Allele Endothelial Cells Lymphatic vessel Malignant Neoplasms Metastasis Suppression Neoplasm Metastasis Receptors, Antigen Secondary Neoplasm cancer cell chemokine primary tumor |
| Content Type | Text |
| Resource Type | Article |